PAPier Giorgio Amendola

Pier Giorgio Amendola

*This is an algorithmically generated author record based on publicly available information.

Pier Giorgio Amendola has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Elisabetta Salcini

    Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark

    4 shared publications
  • A Molchadsky

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

    1 shared publication
  • Alba Redo Riveiro

    Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

    1 shared publication
  • Alessia Varone

    Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore”, National Research Council, Naples, Italy

    1 shared publication
  • Angela Filograna

    Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore”, National Research Council, Naples, Italy

    1 shared publication
  • Antoni Castells

    Gastroenterology, Hospital Clínic of Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, Barcelona, Spain

    1 shared publication

Latest Publications

  • Open Access

    Shp1 phosphatase regulates CXCR2 protein stability and IL8-mediated invasiveness in breast cancer

    by Marcello Monti, Pier Giorgio Amendola, Angela Filograna, Sabrina Gargiulo, Marcello Allegretti, Daniela Corda, Alessia Varone

    Shp1 is a cytosolic tyrosine phosphatase generally associated with antitumor effects through the inhibition of tyrosine kinase signaling. Herein, we shown that genetic and pharmacological inhibition of Shp1 in breast cancer cells induces accelerated cell migration and promotes a more invasive phenotype. Furthermore, we found that interleukin-8 (IL8), a chemokine with multiple pro-tumorigenic roles within the tumor microenvironment, directly modulates Shp1 activity. In breast cancer, IL8 elicits its functions through the binding to the CXCR2 receptor with the subsequent modulation of several intracellular signaling pathways. We show that in breast MCF7 cells, IL8 induces the PKC-mediated phosphorylation of Shp1 at Ser591, diminishing its enzymatic activity and impairing the dephosphorylation of PP2A; this enhances CXCR2 phosphorylation and alters receptor trafficking by promoting ubiquitination and degradation of CXCR2. This feedback mechanism limits IL8 signaling revealing a previously unrecognized mechanism of receptor turnover and signal attenuation. In addition, we found that Shp1-mediated regulation of CXCR2 directly influences IL8-driven invasiveness in a subtype-specific manner, affecting luminal and triple-negative breast cancer (TNBC) cells but not HER2-positive ones. Transcriptomic and pathway analyses further support Shp1 involvement in cytokine and GPCR signaling, particularly in TNBC, where its downregulation correlates with reduced survival and higher IL8 levels. Taken together, our findings elucidate a novel mechanism of IL8 signaling and identify Shp1 as a promising therapeutic target, highlighting the potential of modulating the CXCR2–Shp1 axis to limit invasiveness and metastasis in aggressive breast cancer subtypes, particularly TNBC.

  • Open Access

    Coordinated maintenance of H3K36/K27 methylation by histone demethylases preserves germ cell identity and immortality

    by Nico Zaghet, Katrine Madsen, Federico Rossi, Daniel Fernandez Perez, Pier Giorgio Amendola, Samuel Demharter, Ulrich Pfisterer, Konstantin Khodosevich, Diego Pasini, Anna Elisabetta Salcini


  • Open Access

    Interplay Between LOX Enzymes and Integrins in the Tumor Microenvironment

    by Pier Giorgio Amendola, Raphael Reuten, Janine Terra Erler

    Members of the lysyl oxidase (LOX) family are secreted copper-dependent amine oxidases that catalyze the covalent crosslinking of collagens and elastin in the extracellular matrix (ECM), an essential process for the structural integrity of all tissues. LOX enzymes can also remodel the tumor microenvironment and have been implicated in all stages of tumor initiation and progression of many cancer types. Changes in the ECM can influence several cancer cell phenotypes. Integrin adhesion complexes (IACs) physically connect cells with their microenvironment. This review article summarizes the main findings on the role of LOX proteins in modulating the tumor microenvironment, with a particular focus on how ECM changes are integrated by IACs to modulate cells behavior. Finally, we discuss how the development of selective LOX inhibitors may lead to novel and effective therapies in cancer treatment.


  • Open Access

    JMJD-1.2 controls multiple histone post-translational modifications in germ cells and protects the genome from replication stress

    by Toshia R. Myers, Pier Giorgio Amendola, Yvonne C. Lussi, Anna Elisabetta Salcini

    Post-translational modifications of histones, constitutive components of chromatin, regulate chromatin compaction and control all DNA-based cellular processes. C. elegans JMJD-1.2, a member of the KDM7 family, is a demethylase active towards several lysine residues on Histone 3 (H3), but its contribution in regulating histone methylation in germ cells has not been fully investigated. Here, we show that jmjd-1.2 is expressed abundantly in the germline where it controls the level of histone 3 lysine 9, lysine 23 and lysine 27 di-methylation (H3K9/K23/K27me2) both in mitotic and meiotic cells. Loss of jmjd-1.2 is not associated with major defects in the germ cells in animals grown under normal conditions or after DNA damage induced by UV or ionizing irradiation. However, jmjd-1.2 mutants are more sensitive to replication stress and the progeny of mutant animals exposed to hydroxyurea show increased embryonic lethality and mutational rate, compared to wild-type. Thus, our results suggest a role for jmjd-1.2 in the maintenance of genome integrity after replication stress and emphasize the relevance of the regulation of histone methylation in genomic stability.


  • Open Access

    JMJD-5/KDM8 regulates H3K36me2 and is required for late steps of homologous recombination and genome integrity

    by Pier Giorgio Amendola, Nico Zaghet, João J. Ramalho, Jens Vilstrup Johansen, Mike Boxem, Anna Elisabetta Salcini

    The eukaryotic genome is organized in a three-dimensional structure called chromatin, constituted by DNA and associated proteins, the majority of which are histones. Post-translational modifications of histone proteins greatly influence chromatin structure and regulate many DNA-based biological processes. Methylation of lysine 36 of histone 3 (H3K36) is a post-translational modification functionally relevant during early steps of DNA damage repair. Here, we show that the JMJD-5 regulates H3K36 di-methylation and it is required at late stages of double strand break repair mediated by homologous recombination. Loss of jmjd-5 results in hypersensitivity to ionizing radiation and in meiotic defects, and it is associated with aberrant retention of RAD-51 at sites of double strand breaks. Analyses of jmjd-5 genetic interactions with genes required for resolving recombination intermediates (rtel-1) or promoting the resolution of RAD-51 double stranded DNA filaments (rfs-1 and helq-1) suggest that jmjd-5 prevents the formation of stalled postsynaptic recombination intermediates and favors RAD-51 removal. As these phenotypes are all recapitulated by a catalytically inactive jmjd-5 mutant, we propose a novel role for H3K36me2 regulation during late steps of homologous recombination critical to preserve genome integrity. DNA damage repair occurs in the context of chromatin and it is influenced by post-translational modifications of histone proteins. The level of methylation at lysine 36 of histone 3 (H3K36) plays an important role in early phases of DNA damage repair by recruiting early repair factors at the site breaks and regulating the formation of RAD-51 foci. Here, we suggest that the regulation of H3K36me2 levels by JMJD-5 is also relevant at later stages of DNA repair. By using C. elegans as model system, we show that loss of jmjd-5, resulting in increased levels of H3K36me2, impairs the resolution of recombination intermediates and the release of RAD-51, with consequences in the DNA repair process after ionizing radiation and in meiotic recombination. Thus, our work provides further insights into the mechanism regulating H3K36 methylation and its central role in repair of double strand breaks and in genome stability.


  • Open Access

    JMJD-1.2/PHF8 controls axon guidance by regulating Hedgehog-like signaling

    by Alba Redo Riveiro, Luca Mariani, Emily Malmberg, Pier Giorgio Amendola, Juhani Peltonen, Garry Wong, Anna Elisabetta Salcini

    Components of the KDM7 family of histone demethylases are implicated in neuronal development and one member, PHF8, is also found mutated in cases of X-linked mental retardation. However, how PHF8 regulates neurodevelopmental processes and contributes to the disease is still largely missing. Here we show that the catalytic activity of a PHF8 homolog in Caenorhabditis elegans, JMJD-1.2, is required non-cell autonomously for proper axon guidance. Loss of JMJD-1.2 deregulates the transcription of the Hedgehog-related genes wrt-8 and grl-16 whose overexpression is sufficient to induce the axonal defects. Deficiency of either wrt-8 or grl-16, or reduced expression of homologs of genes promoting Hedgehog signaling restore correct axon guidance in jmjd-1.2 mutant. Genetic and overexpression data indicate that Hedgehog-related genes act on axon guidance through actin remodelers. Thus, our study highlights a novel function of jmjd-1.2 in axon guidance that may be relevant for the onset of X-linked mental retardation and provides compelling evidences of a conserved function of the Hedgehog pathway in C. elegans axon migration.


  • ZEB1 Promotes Invasiveness of Colorectal Carcinoma Cells through the Opposing Regulation of uPA and PAI-1

    by Ester Sánchez-Tilló, Oriol de Barrios, Laura Siles, Pier G. Amendola, Douglas S. Darling, Miriam Cuatrecasas, Antoni Castells, Antonio Postigo

    Purpose: Carcinoma cells enhance their invasive capacity through dedifferentiation and dissolution of intercellular adhesions. A key activator of this process is the ZEB1 transcription factor, which is induced in invading cancer cells by canonical Wnt signaling (β-catenin/TCF4). Tumor invasiveness also entails proteolytic remodeling of the peritumoral stroma. This study aimed to investigate the potential regulation by ZEB1 of the plasminogen proteolytic system constituted by the urokinase plasminogen activator (uPA), and its inhibitor, plasminogen activator inhibitor-1 (PAI-1). Experimental Design: Through multiple experimental approaches, colorectal carcinoma (CRC) cell lines and samples from human primary CRC and ZEB1 (−/−) mice were used to examine ZEB1-mediated regulation of uPA and PAI-1 at the protein, mRNA, and transcriptional level. Results: ZEB1 regulates uPA and PAI-1 in opposite directions: induces uPA and inhibits PAI-1. In vivo expression of uPA depends on ZEB1 as it is severely reduced in the developing intestine of ZEB1 null (−/−) mice. Optimal induction of uPA by Wnt signaling requires ZEB1 expression. ZEB1 binds to the uPA promoter and activates its transcription through a mechanism implicating the histone acetyltransferase p300. In contrast, inhibition of PAI-1 by ZEB1 does not involve transcriptional repression but rather downregulation of mRNA stability. ZEB1-mediated tumor cell migration and invasion depend on its induction of uPA. ZEB1 coexpresses with uPA in cancer cells at the invasive front of CRCs. Conclusions: ZEB1 promotes tumor invasiveness not only via induction in cancer cells of a motile dedifferentiated phenotype but also by differential regulation of genes involved in stroma remodeling. Clin Cancer Res; 19(5); 1071–82. ©2013 AACR.


  • p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity

    by A Molchadsky, O Ezra, P G Amendola, D Krantz, I Kogan-Sakin, Y Buganim, N Rivlin, N Goldfinger, V Folgiero, R Falcioni, et al.

    Proper regulation of white and brown adipogenic differentiation is important for maintaining an organism's metabolic profile in a homeostatic state. The recent observations showing that the p53 tumor suppressor plays a role in metabolism raise the question of whether it is involved in the regulation of white and brown adipocyte differentiation. By using several in vitro models, representing various stages of white adipocyte differentiation, we found that p53 exerts a suppressive effect on white adipocyte differentiation in both mouse and human cells. Moreover, our in vivo analysis indicated that p53 is implicated in protection against diet-induced obesity. In striking contrast, our data shows that p53 exerts a positive regulatory effect on brown adipocyte differentiation. Abrogation of p53 function in skeletal muscle committed cells reduced their capacity to differentiate into brown adipocytes and histological analysis of brown adipose tissue revealed an impaired morphology in both embryonic and adult p53-null mice. Thus, depending on the specific adipogenic differentiation program, p53 may exert a positive or a negative effect. This cell type dependent regulation reflects an additional modality of p53 in maintaining a homeostatic state, not only in the cell, but also in the organism at large.